supporting information - royal society of chemistry · 3 general procedure of n-alkylation of...
TRANSCRIPT
1
Supporting Information
Fine-tuning the regio- and chemoselective alkylation of 1,4-benzodiazepines:
Further applications of the Mitsunobu reaction
Kwan-Young Junga and Steven Fletcher*
a,b
aDepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N Pine St.,
Baltimore, MD 21201, USA. E-mail: [email protected]; Fax: +1-410-706-5017; Tel: +1-
410-706-6361
bUniversity of Maryland Marlene and Stewart Greenebaum Cancer Center, 22 S Greene St, Baltimore,
MD 21201, USA
General.
Unless otherwise stated, all reactions were performed under an inert (N2) atmosphere. Reagents and
solvents were reagent grade and purchased from Sigma-Aldrich, Alfa Aesar, Oakwood and TCI
America. 1H and
13C NMR spectra were recorded on Varian INOVA 400 MHz and Varian INOVA 500
MHz NMR spectrometers at 25 °C. Chemical shifts are reported in parts per million (ppm). The
residual solvent peak was used as an internal reference. The mass spectra were obtained on an
Electrospray TOF (ESI-TOF) mass spectrometer (Bruker amaZon X). IR spectra were recorded on an
FT-IR 400 spectrometer (JASCO). Melting points were obtained using a MEL-TEMP II (Laboratory
Devices, Inc. USA).
Abbreviations.
EtOAc, ethyl acetate; MeOH, methanol; DMSO, dimethyl sulfoxide; DMF, N,N-dimethylformamide;
THF, tetrahydrofuran; Et2O, diethyl ether; CH3CN, acetonitrile; CH2Cl2, dichloromethane; CHCl3,
chloroform; HNEt2, diethylamine; IBCF, isobutyl chloroformate; NMM, N-methylmorpholine; NH4Cl,
ammonium chloride; Na2SO4, sodium sulfate; K2CO3, potassium carbonate; NaHCO3, sodium
bicarbonate; DIAD, diisopropyl azodicarboxylate; PBu3, tributylphosphine; PPh3, triphenylphosphine;
PMe3, trimethylphosphine; PCy3, tricyclohexylphosphine; SOCl2, thionyl chloride; (COCl)2, oxalyl
chloride; DIPEA, N,N-diisopropylethylamine; NaBH(OAc)3, sodium triacetoxyborohydride; p-TsOH,
para-toluenesulfonic acid; Bu4NI, tetrabutylammonium iodide; Na2SO4∙10H2O, sodium sulfate
decahydrate; s, singlet; d, doublet; t, triplet; q, quartet; pent, pentet; sep, septet; dd, doublet of
doublets; dt, doublet of triplets; dq, doublet of quartets.
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
2
Experimental Section.
Aspartic acid dimethyl ester∙HCl (6). Aspartic acid 5 (3.0 g, 22.5 mmol) was dissolved in methanol
(110 mL) and cooled to 0 °C. Thionyl chloride (4.9 mL, 67.6 mmol) was added dropwise at 0 °C and
the reaction mixture was stirred for 3 h at 50 °C. The reaction solvent and thionyl chloride were
removed by evaporation under reduced pressure to give the product 6 as white solid (4.43 g, 100%):
1H NMR (500 MHz, DMSO-d6) δ 8.74 (2H, s, NH2∙HCl), 4.35 (1H, m, CHNH2), 3.76 (3H, s, OCH3),
3.65 (3H, s, OCH3), 3.02 (2H, m, CH2).
(S)-Methyl 2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-3-yl)acetate (1). Aspartic
acid dimethyl ester∙HCl 6 (1.53 g, 9.38 mmol) and isatoic anhydride (1.85 g, 9.38 mmol) were
dissolved in pyridine (20 mL) then the reaction mixture was stirred for 24 h at 120 °C. The pyridine
was removed by evaporation under reduced pressure and the residue was re-dissolved in ethyl acetate
then partitioned between ethyl acetate and 1N HCl aqueous solution. The organic layer was collected,
dried over anhydrous Na2SO4, filtered, and concentrated. The light brown solid was washed with
water (3 x 10 mL) and diethyl ether (3 x 10 mL) to give product 1 as light brown solid (1.05 g, 45.0%):
Mp 230-232 °C; 1H NMR (500 MHz, DMSO-d6) δ 10.48 (1H, s, NH), 8.59 (1H, d, J=4.5 Hz, NH),
7.76 (1H, d, J=8.0 Hz, phenyl), 7.54 (1H, t, J=8.0 Hz, phenyl), 7.26 (1H, t, J=8.0 Hz, phenyl), 7.13
(1H, d, J=8.0 Hz, phenyl), 4.04 (1H, m, CHCH2), 3.58 (3H, s, OCH3), 2.88 (1H, dd, J=8.0 Hz, 8.5 Hz,
CHCH2), 2.73 (1H, dd, J=6.0 Hz, 6.5 Hz, CHCH2); 13
C NMR (125 MHz, DMSO-d6) δ 170.7, 170.5,
167.6, 136.5, 132.3, 130.4, 126.1, 124.2, 121.0, 51.5, 48.5, 32.4; I.R. (neat): ν/cm-1
3102, 3023, 1735,
1681, 1656, 1446, 1269, 1183, 756; MS (ESI) m/z Calcd for C12H12N2O4+H (M+H+): 249.0, Found:
249.1.
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
3
General procedure of N-alkylation of compound 1 using potassium carbonate.
Compound 1 (50 mg, 0.20 mmol) and K2CO3 (83 mg, 0.60 mmol) were added to the reaction flask
containing 4 mL of DMF. The reaction mixture was stirred at room temperature for 20 min then 2-
iodopropane (50 µL, 0.50 mmol) or benzyl bromide (120 µL, 0.50 mmol) was added. The reaction
mixture was stirred at 60 °C (2-iodopropane) or at room temperature (benzyl bromide) overnight. The
reaction was quenched by adding H2O (4 mL), then partitioned between EtOAc and sat’d NH4Cl (aq).
The organic layer was collected, dried over anhydrous Na2SO4, filtered, concentrated, and purified by
column chromatography on silica gel to give the compound N-2c (R=benzyl) or N-2e (R-isopropyl).
(S)-methyl 2-(1-benzyl-2,5-dioxo-2,3,4,5-tetrahydro-1H-
benzo[e][1,4]diazepin-3-yl)acetate (N-2c). Yield = 45.6 mg, 67.0%;
White solid; Mp 73-74 °C; 1H NMR (500 MHz, DMSO-d6) δ 8.81 (1H, d,
J=6.0 Hz, NH), 7.67 (1H, d, J=8.0 Hz, phenyl), 7.56 (1H, t, J=7.5 Hz,
phenyl), 7.47 (1H, d, J=7.5 Hz, phenyl), 7.32 (1H, t, J=8.0 Hz, phenyl),
7.25 (2H, t, J=8.0 Hz, phenyl), 7.19 (1H, t, J=7.5 Hz, phenyl), 7.09 (2H, d,
J=7.5 Hz, phenyl), 5.24 (1H, d, J=15.5 Hz, CH2C6H5), 5.05 (1H, d, J=15.5 Hz, CH2C6H5), 4.20-4.16
(1H, m, CHCH2), 3.59 (3H, s, OCH3), 2.97 (1H, dd, J=10.0 Hz, J=8.5 Hz, CHCH2), 2.79 (1H, dd,
J=5.5 Hz, J=5.5 Hz, CHCH2); 13
C NMR (125 MHz, DMSO-d6) δ 170.5, 169.7, 167.3, 139.1, 137.1,
132.2, 129.7, 129.5, 128.4, 127.0, 126.6, 125.9, 122.3, 51.6, 49.8, 48.8, 32.7; I.R. (neat): ν/cm-1
3108,
1662, 1601, 1460, 1399, 1252, 1185, 764, 731, 698; MS (ESI) m/z Calcd for C19H18N2O4+H (M+H+):
339.1, Found: 339.2.
(S)-methyl 2-(1-isopropyl-2,5-dioxo-2,3,4,5-tetrahydro-1H-
benzo[e][1,4]diazepin-3-yl)acetate (N-2e) Yield = 11.1 mg, 19.0 %;
White solid; Mp 146-148 °C; 1H NMR (500 MHz, DMSO-d6) δ 8.68 (1H,
d, J=4.8 Hz, NH), 7.68 (1H, d, J=8.0 Hz, phenyl), 7.62 (1H, t, J=8.0 Hz,
phenyl), 7.45 (1H, d, J=8.0 Hz, phenyl), 7.40 (1H, t, J=8.0 Hz, phenyl),
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
4
4.36 (1H, sep, J=7.0 Hz, CH(CH3)2), 3.96 (1H, q, J=6.0 Hz, CHCH2), 3.56 (3H, s, OCH3), 2.89 (1H,
dd, J=8.5 Hz, J=8.0 Hz, CHCH2-1H), 2.69 (1H, dd, J=6.0 Hz, J=6.0 Hz, CHCH2), 1.39 (3H, d, J=6.5
Hz, CH3), 1.18 (3H, d, J=7.0 Hz, CH3); 13
C NMR (125 MHz, DMSO-d6) δ 170.6, 169.5, 167.4, 138.8,
131.8, 130.4, 129.1, 126.4, 124.1, 52.0, 51.5, 49.7, 32.5, 21.3, 20.1; I.R. (neat): ν/cm-1
3202, 1655,
1641, 1598, 1458, 1368, 1196, 1154, 771; MS (ESI) m/z Calcd for C15H18N2O4+H (M+H+): 291.1,
Found: 291.1.
General procedure of N- or O-alkylation of compound 1 using Mitsunobu reaction.
Compound 1 (40 mg, 0.16 mmol), the appropriate alcohol (0.40 mmol), and triphenylphosphine (99
µL, 0.40 mmol) were added to the reaction flask containing 5 mL of THF under an inert (N2)
atmosphere. The reaction mixture was stirred for 5 min. at room temperature and then DIAD (79 µL,
0.40 mmol) was added slowly. The reaction mixture was then stirred for 4 h at room temperature. The
reaction solvent was removed by evaporation under reduced pressure and the residue was purified by
column chromatography on silica gel (hexanes–EtOAc, 1:9) to afford product.
(S)-Methyl 2-(2,5-dioxo-1-(prop-2-yn-1-yl)-2,3,4,5-tetrahydro-1H-
benzo[e][1,4]diazepin-3-yl)acetate (N-2a). Yield = 42.9 mg, 93.0%;
White solid; Mp 50-51 °C; 1H NMR (500 MHz, DMSO-d6) δ 8.74 (1H, d,
J=5.0 Hz, NH), 7.73 (1H, d, J=6.5 Hz, phenyl), 7.69-7.63 (2H, m, phenyl),
7.40 (1H, t, J=7.0 Hz, phenyl), 4.74 (1H, d, J= 18.5 Hz, CH2C≡CH), 4.64
(1H, d, J=18.5 Hz, CH2C≡CH), 4.09-4.05 (1H, m, CH(CH3)2), 3.57 (3H, s, OCH3), 3.19 (1H, s,
CH2C≡CH), 2.94 (1H, dd, J= 9.0 Hz, 7.5 Hz, CHCH2), 2.76 (1H, dd, J=5.5 Hz, 5.0 Hz, CHCH2); 13
C
NMR (125 MHz, DMSO-d6) δ 170.4, 169.1, 167.2, 138.5, 132.3, 129.7, 129.2, 126.2, 122.2, 79.3,
74.8, 51.6, 48.7, 36.4, 32.6; I.R. (neat): ν/cm-1
3302, 3015, 1735, 1661, 1602, 1460, 1374, 1249, 1192,
765; MS (ESI) m/z Calcd for C15H14N2O4+H (M+H+): 287.1, Found: 287.0.
(S)-Methyl 2-(1-allyl-2,5-dioxo-2,3,4,5-tetrahydro-1H-
benzo[e][1,4]diazepin-3-yl)acetate (N-2b). Yield = 43.8 mg, 94.3%;
White solid; Mp 60-62 °C; 1H NMR (500 MHz, DMSO-d6) δ 8.76 (1H, d,
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
5
J=5.0 Hz, NH), 7.71 (1H, d, J=7.0 Hz, phenyl), 7.61 (1H, t, J=8.0 Hz, phenyl), 7.48 (1H, d, J=8.0 Hz,
phenyl), 7.36 (1H, t, J=8.0 Hz, phenyl), 5.78-5.72 (1H, m, CH2CH=CH2), 5.08 (2H, d, J=10.5 Hz,
CH2CH=CH2), 4.52 (2H, dd, J=16.5 Hz, 16.5 Hz, CH2CH=CH2), 4.12-4.10 (1H, m, CH(CH3)2), 3.57
(3H, s, OCH3), 2.92 (1H, dd, J=8.5 Hz, 8.5 Hz, CHCH2), 2.75 (1H, dd, J=4.5 Hz, 2.0 Hz, CHCH2);
13C NMR (125 MHz, DMSO-d6) δ 170.5, 169.2, 167.4, 139.3, 133.1, 132.3, 129.6, 129.3, 125.8,
122.2, 116.4, 51.5, 49.4, 48.8, 32.7; I.R. (neat): ν/cm-1
3310, 2200, 1706, 1660, 1602, 1460, 1399,
1375, 1193, 765; MS (ESI) m/z Calcd for C15H16N2O4+H (M+H+): 289.1, Found: 289.0.
(S)-Methyl 2-(1-benzyl-2,5-dioxo-2,3,4,5-tetrahydro-1H-
benzo[e][1,4]diazepin-3-yl)acetate (N-2c). Yield = 41.6 mg, 76.3%;
White solid; Mp 71-74 °C; 1H NMR (500 MHz, DMSO-d6) δ 8.82 (1H, d,
J=6.0 Hz, NH), 7.68 (1H, d, J=8.0 Hz, phenyl), 7.56 (1H, t, J=7.5 Hz,
phenyl), 7.48 (1H, d, J=7.5 Hz, phenyl), 7.32 (1H, t, J=8.0 Hz, phenyl),
7.25 (2H, t, J=8.0 Hz, phenyl), 7.19 (1H, t, J=7.5 Hz, phenyl), 7.10 (2H, d,
J=8.5 Hz, phenyl), 5.26 (1H, d, J=16.5 Hz, CH2C6H5), 5.04 (1H, d, J=16.5 Hz, CH2C6H5), 4.21-4.17
(1H, m, CHCH2), 3.59 (3H, s, OCH3), 2.97 (1H, dd, J=8.5 Hz, J=8.5 Hz, CHCH2), 2.79 (1H, dd,
J=5.5 Hz, J=4.5 Hz, CHCH2); 1H NMR (400 MHz, CDCl3) δ 7.84 (1H, d, J=8.0 Hz, phenyl), 7.44
(1H, t, J=8.0 Hz, phenyl), 7.30-7.21 (5H, m, phenyl), 7.14 (1H, t, J=8.0 Hz, phenyl), 6.81 (1H, d,
J=5.6 Hz, NH), 5.16 (1H, d, J=15.6 Hz, CH2C6H5), 5.00 (1H, d, J=15.6 Hz, CH2C6H5), 4.38-4.35 (1H,
m, CHCH2), 3.71 (3H, s, OCH3), 3.06 (1H, dd, J=8.0 Hz, J=8.0 Hz, CHCH2), 2.77 (1H, dd, J=5.6 Hz,
J=5.2 Hz, CHCH2); 13
C NMR (125 MHz, DMSO-d6) δ 170.5, 169.7, 167.3, 139.1, 137.1, 132.2, 129.7,
129.5, 128.4, 127.0, 126.6, 125.9, 122.3, 51.6, 49.8, 48.8, 32.7; I.R. (neat): ν/cm-1
3108, 1662, 1601,
1460, 1399, 1252, 1185, 764, 731, 698; MS (ESI) m/z Calcd for C19H18N2O4+H (M+H+): 339.1,
Found: 339.2.
(S)-Methyl 2-(2-(benzyloxy)-5-oxo-4,5-dihydro-3H-
benzo[e][1,4]diazepin-3-yl)acetate (O-2c). Yield = 7.6 mg, 14.0%;
Colorless sticky oil; 1H NMR (500 MHz, DMSO-d6) δ 8.64 (1H, d, J=5.0
Hz, NH), 7.78 (1H, d, J=7.5 Hz, phenyl), 7.55 (1H, t, J=8.0 Hz, phenyl),
7.40-7.35 (5H, m, phenyl), 7.26 (1H, t, J=7.5 Hz, phenyl), 7.18 (1H, d,
J=8.5 Hz, phenyl), 5.36 (1H, d, J=13.0 Hz, CH2C6H5), 5.24 (1H, d, J=13.0
Hz, CH2C6H5), 4.09 (1H, q, J=7.0 Hz, CHCH2), 3.54 (3H, s, OCH3), 2.92 (1H, dd, J=9.0 Hz, J=8.5 Hz,
CHCH2), 2.83 (1H, dd, J=7.0 Hz, J=6.0 Hz, CHCH2); 13
C NMR (125 MHz, DMSO-d6) δ 170.3, 169.5,
161.6, 144.3, 135.6, 132.4, 130.4, 128.5, 128.4, 128.2, 128.1, 126.4, 124.5, 69.2, 52.0, 47.5, 32.9; I.R.
(neat): ν/cm-1
2989, 1739, 1654, 1308, 1254, 1153, 766, 730, 697; MS (ESI) m/z Calcd for
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
6
C19H18N2O4+H (M+H+): 339.1, Found: 339.1.
(S)-Methyl 2-(1-butyl-2,5-dioxo-2,3,4,5-tetrahydro-1H-
benzo[e][1,4]diazepin-3-yl)acetate (N-2d). Yield = 29.6 mg, 60.3%;
White solid; Mp 55-58 °C; 1H NMR (500 MHz, DMSO-d6) δ 8.73 (1H, d,
J=5.0 Hz, NH), 7.70 (1H, d, J=8.0 Hz, phenyl), 7.63 (1H, t, J=8.0 Hz,
phenyl), 7.56 (1H, d, J=7.5 Hz, phenyl), 7.37 (1H, t, J=7.5 Hz, phenyl),
4.25 (1H, pent, J=7.0 Hz, CH2CH2CH2CH3), 4.02 (1H, q, J=6.0 Hz,
CHCH2), 3.65 (1H, pent, J=7.0 Hz, CH2CH2CH2CH3), 3.56 (3H, s, OCH3), 2.90 (1H, dd, J=9.0 Hz,
J=9.0 Hz, CHCH2), 2.72 (1H, dd, J=6.0 Hz, J=6.0 Hz, CHCH2), 1.33 (1H, m, CH2CH2CH2CH3), 1.26
(1H, m, CH2CH2CH2CH3), 1.10 (2H, m, CH2CH2CH2CH3), 0.76 (3H, t, J=7.0 Hz, CH2CH2CH2CH3);
13C NMR (125 MHz, DMSO-d6) δ 170.6, 169.4, 167.4, 138.8, 132.3, 129.9, 129.5, 125.9, 122.9, 51.5,
48.9, 45.7, 32.6, 29.2, 18.9, 13.4; I.R. (neat): ν/cm-1
3002, 1738, 1661, 1601, 1460, 1402, 1373, 1193,
790, 767; MS (ESI) m/z Calcd for C16H20N2O4+H (M+H+): 305.1, Found: 305.1.
(S)-Methyl 2-(2-butoxy-5-oxo-4,5-dihydro-3H-benzo[e][1,4]diazepin-
3-yl)acetate (O-2d). Yield = 17.2 mg, 35.1%; Colorless sticky oil; 1H
NMR (500 MHz, DMSO-d6) δ 8.61 (1H, s, NH), 7.76 (1H, d, J=7.0 Hz,
phenyl), 7.52 (1H, t, J=7.5 Hz, phenyl), 7.23 (1H, t, J=7.5 Hz, phenyl),
7.13 (1H, d, J=7.5 Hz, phenyl), 4.27 (1H, pent, J=6.5 Hz,
CH2CH2CH2CH3), 4.14 (1H, pent, J=6.5 Hz, CH2CH2CH2CH3), 4.01 (1H,
q, J=5.5 Hz, CHCH2), 3.59 (3H, s, OCH3), 2.88 (1H, dd, J=9.5 Hz, J=8.5 Hz, CHCH2), 2.81 (1H, dd,
J=6.0 Hz, J=6.0 Hz, CHCH2), 1.63 (2H, m, CH2CH2CH2CH3), 1.38 (2H, m, CH2CH2CH2CH3), 0.91
(3H, t, J=7.5 Hz, CH2CH2CH2CH3); 13
C NMR (125 MHz, DMSO-d6) δ 170.3, 167.7, 163.3, 144.1,
131.8, 129.8, 126.8, 125.8, 124.0, 66.4, 51.6, 46.8, 32.3, 29.9, 18.5, 13.6; I.R. (neat): ν/cm-1
2924,
1654, 1601, 1314, 1254, 1014, 766, 725; MS (ESI) m/z Calcd for C16H20N2O4+H (M+H+): 305.1,
Found: 305.1.
(S)-Methyl 2-(1-isopropyl-2,5-dioxo-2,3,4,5-tetrahydro-1H-
benzo[e][1,4]diazepin-3-yl)acetate (N-2e). Yield = 13.7 mg, 29.2%;
White solid; Mp 145-148 °C; 1H NMR (500 MHz, DMSO-d6) δ 8.68 (1H,
d, J=4.8 Hz, NH), 7.68 (1H, d, J=8.0 Hz, phenyl), 7.62 (1H, t, J=8.0 Hz,
phenyl), 7.45 (1H, d, J=8.0 Hz, phenyl), 7.40 (1H, t, J=8.0 Hz, phenyl),
4.36 (1H, sep, J=7.0 Hz, CH(CH3)2), 3.96 (1H, q, J=6.0 Hz, CHCH2), 3.56 (3H, s, OCH3), 2.89 (1H,
dd, J=8.5 Hz, J=8.0 Hz, CHCH2), 2.69 (1H, dd, J=6.0 Hz, J=6.0 Hz, CHCH2), 1.39 (3H, d, J=6.5 Hz,
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
7
CH3), 1.18 (3H, d, J=7.0 Hz, CH3); 13
C NMR (125 MHz, DMSO-d6) δ 170.6, 169.5, 167.4, 138.8,
131.8, 130.4, 129.1, 126.4, 124.0, 52.0, 51.5, 49.7, 32.5, 21.3, 20.0; I.R. (neat): ν/cm-1
3202, 1655,
1641, 1598, 1458, 1368, 1196, 1154, 771; MS (ESI) m/z Calcd for C15H18N2O4+H (M+H+): 291.1,
Found: 291.1.
(S)-Methyl 2-(2-isopropoxy-5-oxo-4,5-dihydro-3H-
benzo[e][1,4]diazepin-3-yl)acetate (O-2e). Yield = 21.6 mg, 46.1%;
Colorless sticky oil; 1H NMR (400 MHz, DMSO-d6) δ 8.56 (1H, d, J=4.8
Hz, NH), 7.72 (1H, d, J=7.6 Hz, phenyl), 7.48 (1H, t, J=7.2 Hz, phenyl),
7.18 (1H, t, J=7.2 Hz, phenyl), 7.09 (1H, d, J=8.0 Hz, phenyl), 5.12 (1H,
sep, J=5.6 Hz, CH(CH3)2), 3.93 (1H, q, J=7.2 Hz, CHCH2), 3.56 (3H, s, OCH3), 2.84-2.74 (2H, m,
CHCH2), 1.22 (3H, d, J=6.4 Hz, CH3), 1.18 (3H, d, J=6.4 Hz, CH3); 13
C NMR (125 MHz, DMSO-d6)
δ 170.3, 167.7, 162.5, 144.2, 131.8, 129.8, 126.8, 125.8, 123.9, 69.4, 51.6, 46.9, 32.3, 21.1, 21.0; I.R.
(neat): ν/cm-1
3012, 1741, 1650, 1601, 1372, 1309, 1106, 994, 765; MS (ESI) m/z Calcd for
C15H18N2O4+H (M+H+): 291.1, Found: 291.1.
2-(2-(9H-fluoren-9-yl)acetamido)-N-(2-acetylphenyl)acetamide (9). To a cooled solution of Fmoc -
glycine 8 (2.75 g, 9.26 mmol) in THF was added N-methylmorpholine (NMM, 1.57 mL, 12.04 mmol)
and isobutyl chloroformate (IBCF, 1.32 mL, 12.04 mmol) at 0 °C then the reaction mixture was
stirred for 20 min. 2′-Aminoacetophenone 7 (1.01 mL, 8.33 mmol) was added and the reaction
mixture was refluxed for 4 h. The reaction solvent was removed under reduced pressure, and the
residue was partitioned between water (50 mL) and EtOAc (3 x 40 mL). The organic layers were
collected, dried over anhydrous Na2SO4, filtered, and evaporated under reduced pressure. The residue
was purified by column chromatography on silica gel (hexanes–EtOAc, 2:1) to afford compound 9 as
white solid (2.65 g, 76.9%): 1H NMR (400 MHz, DMSO-d6) δ 11.93 (1H, s, NH), 8.56 (1H, d, J=8.8
Hz, phenyl), 8.11 (1H, s, NH), 8.07 (1H, d, J=7.6 Hz, phenyl), 7.92 (2H, d, J=7.2 Hz, Fmoc), 7.79
(2H, d, J=6.8 Hz, Fmoc), 7.64 (1H, t, J=6.8 Hz, phenyl), 7.44 (2H, t, J=6.8 Hz, Fmoc), 7.35 (2H, t,
J=7.2 Hz, Fmoc), 7.24 (1H, t, J=7.6 Hz, phenyl), 4.38 (2H, d, J=6.0 Hz, CH2-Fmoc), 4.32 (1H, m,
Fmoc), 3.82 (2H, d, J=4.8 Hz, C(O)CH2), 2.63 (3H, s, C(O)CH3); 13
C NMR (100 MHz, DMSO-d6) δ
202.7, 169.2, 156.8, 143.8, 140.7, 139.7, 134.6, 132.2, 127.6, 127.0, 125.3, 122.9, 122.8, 120.7, 119.8,
66.1, 66.1, 46.6, 45.3, 28.7.
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
8
5-Methyl-1H-benzo[e][1,4]diazepin-2(3H)-one (3). Compound 9 (2.58 g, 6.23 mmol) was dissolved
in 20% diethylamine solution in CH3CN and the reaction mixture was stirred for 1 h at room
temperature. The reaction solvent and diethylamine were removed under reduced pressure. The
residue was purified by column chromatography on silica gel (hexanes–EtOAc, 1:3) to afford
compound 3 as white solid (0.94 g, 86.4%): Mp 178-181 °C; 1H NMR (400 MHz, DMSO-d6) δ 10.41
(1H, s, NH), 7.71 (1H, d, J=7.6 Hz, phenyl), 7.49 (1H, t, J=6.8 Hz, phenyl), 7.20 (1H, t, J=6.8 Hz,
phenyl), 7.14 (1H, d, J=7.6 Hz, phenyl), 3.87 (2H, s, CH2), 2.40 (3H, s, CH3); 13
C NMR (100 MHz,
DMSO-d6) δ170.2, 168.9, 137.6, 131.0, 128.6, 128.0, 123.2, 120.9, 56.1, 25.6; I.R. (neat): ν/cm-1
3014,
1737, 1658, 1601, 1461, 1374, 1194, 768; MS (ESI) m/z Calcd for C10H10N2O+H (M+H+): 175.1,
Found: 175.0.
General procedure of Mitsunobu reaction using compound 3
Compound 3 (150 mg, 0.86 mmol), appropriate alcohol (2.15 mmol), and tributylphosphine (530 µL,
2.15 mmol) were added to the reaction flask containing 10 mL of chloroform in N2(g) atmosphere.
The reaction mixture was stirred for 5 min at room temperature and then DIAD (423 μL, 2.15 mmol)
was added slowly. The reaction mixture was stirred for 4 h at room temperature. The reaction solvent
was removed by evaporation under reduced pressure and the residue was purified by column
chromatography on silica gel (hexanes–EtOAc, 1:9) to afford the product.
1-Benzyl-5-methyl-1H-benzo[e][1,4]diazepin-2(3H)-one (4a). Yield = 175.5 mg,
77.3%; White solid; Mp 119-122 °C; 1H NMR (400 MHz, DMSO-d6) δ 7.61 (1H, dd,
J=6.8 Hz, 0.8 Hz, phenyl), 7.46-7.41 (2H, m, phenyl), 7.23-7.17 (3H, m, phenyl),
7.13 (1H, t, J=7.2 Hz, phenyl), 6.97 (2H, d, J=7.6 Hz, phenyl), 5.28 (1H, d, J=15.6
Hz, CH2C6H5), 4.91 (1H, d, J=15.6 Hz, CH2C6H5), 4.32 (1H, d, J=10.8 Hz, NCH2),
3.61 (1H, d, J=10.8 Hz, NCH2), 2.31 (3H, s, CH3); 13
C NMR (100 MHz, DMSO-d6)
δ 169.6, 168.9, 140.5, 137.6, 131.4, 131.3, 128.8, 128.0, 127.4, 127.0, 125.2, 122.6, 56.2, 49.2, 25.4;
I.R. (neat): ν/cm-1
3110, 1738, 1656, 1376, 1228, 778; MS (ESI) m/z Calcd for C17H16N2O+H (M+H+):
265.1, Found: 265.1.
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
9
1-Isopropyl-5-methyl-1H-benzo[e][1,4]diazepin-2(3H)-one (4b). Yield = 63.5 mg,
34.2%; Colorless oil; 1H NMR (400 MHz, DMSO-d6) δ 7.64 (1H, dd, J=6.4 Hz, 1.2
Hz, phenyl), 7.51 (1H, dt, J=5.6 Hz, 1.6 Hz, phenyl), 7.40 (1H, dd, J=5.6 Hz, 0.8 Hz,
phenyl), 7.29 (1h, dt, J=6.4 Hz, 1.2 Hz, phenyl), 4.25 (1H, sep, J=6.8 Hz, CH(CH3)2),
4.13 (1H, d, J=10.8 Hz, NCH2), 3.40 (1H, d, J=10.8 Hz, NCH2), 2.36 (3H, s, CH3), 1.32 (3H, d, J=6.8
Hz, CH3), 1.17 (3H, d, J=6.8 Hz, CH3); 13
C NMR (100 MHz, DMSO-d6) δ 169.4, 169.1, 140.6, 131.8,
130.9, 127.7, 125.6, 123.8, 57.3, 51.6, 25.3, 21.8, 20.4; I.R. (neat): ν/cm-1
3001, 1670, 1630, 1447,
1322, 1250, 756; MS (ESI) m/z Calcd for C13H16N2O+H (M+H+): 217.1, Found: 217.1.
Experimental detail for Mitsunobu reaction using triphenylphosphine resin.
A mixture of compound 1 (15.0 mg, 0.06 mmol), triphenylphosphine resin (“PS-PPh3”; loading
capacity: 2.09 mmol/g, 86 mg, 0.18 mmol) and benzyl alcohol (19 µL, 0.18 mmol) or isopropanol (14
µL, 0.18 mmol) in CHCl3 (2 mL) was gently stirred for 5 min at room temperature. DIAD (36 µL,
0.18 mmol) was added and the reaction mixtures were stirred at room temperature (benzyl alcohol) or
40 °C (isopropanol). The reactions were monitored by thin layer chromatography. The benzyl alcohol
reaction was complete within 3 h, whilst the isopropanol reaction was left overnight to ensure all of 1
was consumed. The NMR spectral data for the major products obtained in the benzyl alcohol and
isopropanol reactions were consistent with those for N-2c and N-2e obtained in the respective solution
phase Mitsunobu reactions.
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
10
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
11
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
12
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
13
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
14
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
15
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
16
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
17
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
18
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
19
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
20
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
21
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
22
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012
23
Electronic Supplementary Material (ESI) for Medicinal Chemistry CommunicationsThis journal is © The Royal Society of Chemistry 2012